A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

760

Participants

Timeline

Start Date

July 27, 2021

Primary Completion Date

August 7, 2030

Study Completion Date

August 7, 2030

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Dapirolizumab pegol

Subjects will receive dapirolizumab pegol at prespecified time-points.

Trial Locations (97)

10032

Sl0046 50334, New York

13617

Sl0046 50366, Canton

17033

Sl0046 50147, Hershey

21740

Sl0046 50015, Hagerstown

25801

Sl0046 50050, Beckley

28211

Sl0046 50238, Charlotte

30303

Sl0046 50368, Atlanta

32174

Sl0046 50059, Ormond Beach

32610

Sl0046 50362, Gainesville

33324

Sl0046 50324, Plantation

33511

Sl0046 50239, Brandon

33606

Sl0046 50329, Tampa

35294

Sl0046 50140, Birmingham

38305

Sl0046 50001, Jackson

48201

Sl0046 50219, Detroit

70605

Sl0046 50285, Lake Charles

76034

Sl0046 50418, Colleyville

80230

Sl0046 50339, Denver

83404

Sl0046 50240, Idaho Falls

85704

Sl0046 50328, Tucson

89128

Sl0046 50273, Las Vegas

90211

Sl0046 50383, Beverly Hills

94578

Sl0046 50316, San Leandro

90623-1730

Sl0046 50275, La Palma

42240-1746

Sl0046 50474, Hopkinsville

Unknown

Sl0046 60002, Buenos Aires

Sl0046 60029, Mendoza

Sl0046 60003, Quilmes

Sl0046 60022, Quilmes

Sl0046 60011, San Juan

Sl0046 60014, San Miguel de Tucumán

Sl0046 40123, Brussels

Sl0046 40189, Plovdiv

Sl0046 40380, Sofia

Sl0046 50374, Calgary

Sl0046 50337, Edmonton AB

Sl0046 50259, Rimouski

Sl0046 50045, Toronto

Sl0046 60015, Santiago

Sl0046 60018, Santiago

Sl0046 60013, Barranquilla

Sl0046 60019, Barranquilla

Sl0046 60006, Bogotá

Sl0046 60027, Bogotá

Sl0046 60016, Bucaramanga

Sl0046 60007, Chía

Sl0046 60031, Montería

Sl0046 40066, Prague

Sl0046 40386, Cologne

Sl0046 40072, Freiburg im Breisgau

Sl0046 40027, Herne

Sl0046 40078, Leipzig

Sl0046 40402, Tübingen

Sl0046 40378, Athens

Sl0046 40501, Athens

Sl0046 40377, Crete

Sl0046 40507, Larissa

Sl0046 40412, Budapest

Sl0046 40411, Debrecen

Sl0046 40031, Szeged

Sl0046 40499, Székesfehérvár

Sl0046 40084, Catania

Sl0046 40448, Milan

Sl0046 50317, Chihuahua City

Sl0046 50250, Cuernavaca

Sl0046 50249, Guadalajara

Sl0046 50271, León

Sl0046 50252, Mérida

Sl0046 50251, Monterrey

Sl0046 60009, Lima

Sl0046 60023, Lima

Sl0046 20182, Davao City

Sl0046 20181, Makati

Sl0046 40482, Bialystok

Sl0046 40119, Bydgoszcz

Sl0046 40398, Katowice

Sl0046 40502, Krakow

Sl0046 40151, Lublin

Sl0046 40044, Poznan

Sl0046 40090, Poznan

Sl0046 40097, Warsaw

Sl0046 40098, Warsaw

Sl0046 40397, Wroclaw

Sl0046 40481, Wroclaw

Sl0046 40382, Galati

Sl0046 40393, Belgrade

Sl0046 40461, Belgrade

Sl0046 20108, Incheon

Sl0046 20104, Seoul

Sl0046 40160, Barcelona

Sl0046 40341, Málaga

Sl0046 40101, Sabadell

Sl0046 40099, Vigo

Sl0046 20113, Taichung

Sl0046 20142, Taichung

Sl0046 20095, Taipei

Sl0046 20082, Taiyuan

All Listed Sponsors
lead

UCB Biopharma SRL

INDUSTRY